Evaluation of Levodopa and Carbidopa Antioxidant Activity in Normal Human Lymphocytes In Vitro: Implication for Oxidative Stress in Parkinson’s Disease-Reference-Cited by-同舟云学术

Evaluation of Levodopa and Carbidopa Antioxidant Activity in Normal Human Lymphocytes In Vitro: Implication for Oxidative Stress in Parkinson’s Disease

Published:2014-10-30 Issue:2 Volume:27 Page:106-117
ISSN:1029-8428
Container-title:Neurotoxicity Research
language:en
Short-container-title:Neurotox Res

Author:

Colamartino Monica,Santoro Massimo,Duranti Guglielmo,Sabatini Stefania,Ceci Roberta,Testa Antonella,Padua Luca,Cozzi Renata

Publisher

Springer Science and Business Media LLC

Subject

Toxicology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1007/s12640-014-9495-7.pdf

Reference60 articles.

1. Abraham S, Soundararajan CC, Vivekanandhan S, Behari M (2005) Erythrocyte antioxidant enzymes in Parkinson’s disease. Indian J Med Res 121:111–115

2. Allen GFG, Ullah Y, Hargreaves IP, Land JM, Heales SJR (2013) Dopamine but not l-dopa stimulates neural glutathione metabolism. Potential implications for Parkinson’s and other dopamine deficiency states. Neurochem Int 62:684–694. doi: 10.1016/j.neuint.2012.12.004

3. Anderson ME (1985) Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 113:548–555

4. Asanuma M, Miyazaki I, Ogawa N (2003) Dopamine- or l-dopa-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease. Neurotox Res 5:165–176

5. Benetello P, Furlanut M, Zara G, Baraldo M, Hassan E (1993) Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa–carbidopa associations. Eur Neurol 33:69–73

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sucralose Targets the Insulin Signaling Pathway in the SH-SY5Y Neuroblastoma Cell Line;Metabolites;2023-07-04

2. L-theanine attenuates LPS-induced motor deficit in experimental rat model of Parkinson’s disease: emphasis on mitochondrial activity, neuroinflammation, and neurotransmitters;Psychopharmacology;2023-05-16

3. Multifunctional magnetoliposomes as drug delivery vehicles for the potential treatment of Parkinson’s disease;Frontiers in Bioengineering and Biotechnology;2023-05-05

4. Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?;Clinical & Translational Immunology;2023-01

5. Moringa oleifera Leaf Extract Protects C2C12 Myotubes against H2O2-Induced Oxidative Stress;Antioxidants;2022-07-24